Astrazeneca and medimmune, announced on top-line results from the galathea phase iii trial for fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary …
Image Gallery
Astrazeneca and medimmune, announced on top-line results from the galathea phase iii trial for fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary …